Oppenheimer & Co’s Teucrium Sugar Fund CANE Stock Holding History

Oppenheimer & Co’s Portfolio CANE Stock Details CANE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-40,599	Closed	-$430K	–	1607
2025 Q3	$430K	Sell	40,599 -19,913	-33%	-$215K	0.01%	1234
2025 Q2	$663K	Buy	60,512 +26,139	+76%	+$300K	0.01%	1036
2025 Q1	$420K	Buy	+34,373	New	+$408K	0.01%	1137

Other funds holding CANE

TIA

Teucrium Investment Advisors Burlington, Vermont $129M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

CBT

Crews Bank & Trust Wauchula, Florida $766M AUM 19.5% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Oppenheimer & Co's CANE Position: Q4 2025 in Review

Oppenheimer & Co sold out of Teucrium Sugar Fund (CANE) in Q4 2025, closing a stake of 40,599 shares — an estimated $430K sold.

Oppenheimer & Co first reported a position in CANE in Q1 2025 and held it in 3 quarters. The position peaked at $663K in Q2 2025. 13 funds tracked by Wall St. Rank hold CANE as of Q4 2025.

Oppenheimer & Co reported no remaining Teucrium Sugar Fund position as of Q4 2025 after selling out during the quarter.
Oppenheimer & Co sold 40,599 Teucrium Sugar Fund shares in Q4 2025, an estimated $430K.
Oppenheimer & Co first reported a position in Teucrium Sugar Fund in Q1 2025 and held it in 3 quarters.
Oppenheimer & Co's Teucrium Sugar Fund position peaked at $663K in Q2 2025.
13 funds tracked by Wall St. Rank held Teucrium Sugar Fund as of Q4 2025.

Based on Oppenheimer & Co's 13F filing for Q4 2025, filed 2 Feb 2026.